Alcohol-related cancer deaths in the United States have doubled since 1990
Mortality linked to drinking has climbed sharply over three decades, driven by rising fatalities from tumors of the digestive tract and breast alongside traditional liver disease.

When people think about the medical hazards of drinking alcohol, liver damage usually comes to mind first. The biological reality of how ethanol travels through human tissue is far wider. Alcohol moves through the mouth, throat, and digestive tract, circulating into the bloodstream and reaching nearly every organ in the body. Along that path, the body breaks ethanol down into toxic byproducts that can directly damage genetic code, interfere with hormone regulation, and promote abnormal cell division. Over time, that repeated cellular injury can initiate tumors in tissues that have little to do with liver cirrhosis.
A long chain of physiological events connects an alcoholic drink to malignant disease. After consumption, digestive enzymes metabolize ethanol into acetaldehyde, a reactive compound that damages cellular DNA and prevents cells from repairing the damage properly. In tissues such as the colon and esophagus, direct exposure to these metabolites triggers local inflammation and accelerates cell turnover. Circulating alcohol also alters levels of hormones such as estrogen, providing chemical fuel for hormone-sensitive tumors. If damaged cells survive and multiply rather than repairing themselves, localized tumors gradually develop and spread.
That biological exposure translates into a growing public health toll across the country. According to a study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, published in The Lancet Regional Health Americas, annual cancer deaths attributed to alcohol in the United States climbed from 11,361 in 1990 to 23,126 in 2023.12 The analysis showed that the fatal burden has more than doubled over three decades, expanding across diverse age groups and tumor types rather than staying confined to chronic liver conditions.12
Which cancers are driving the increase in deaths?
Tumors of the digestive tract and breast now account for a major share of alcohol-attributable fatalities. The researchers reported that while liver cancer historically represented the primary alcohol-linked cancer risk, the toll extends broadly to cancers of the colon, rectum, esophagus, pancreas, stomach, prostate, and breast, as well as head and neck sites.12 The International Agency for Research on Cancer classifies alcohol as a Group 1 human carcinogen, placing it in the same hazard tier as tobacco smoke and asbestos.12

The specific risks differ noticeably across demographic groups. In men aged 55 and older, liver cancer maintained the highest alcohol-attributable mortality rate over the 33-year period, followed by esophageal and colorectal cancers.12 Among women in that same older age bracket, breast cancer was the leading cause of alcohol-linked cancer death, followed by liver and colorectal tumors.12 Overall, the alcohol-related cancer mortality rate among males aged 55 and older rose by nearly 24% between 1990 and 2023.1
The patterns among younger adults proved particularly striking to the investigators. Among adults aged 20 to 54, colorectal cancer was the leading cause of alcohol-attributable cancer death in men and the second leading cause in women, while breast cancer ranked first among younger women.2 In both younger demographic groups, colorectal cancer deaths linked to alcohol surpassed liver cancer deaths.2
How did the researchers track mortality trends over three decades?
Researchers examined long-term population patterns by conducting a secondary analysis of Global Burden of Disease data covering the years 1990 through 2023.21 The underlying database pools vital statistics, disease registries, and epidemiological surveys to calculate the proportion of specific cancer deaths that can be mathematically attributed to recorded levels of alcohol intake. By modeling intake levels against established relative risk curves for distinct malignancies, the authors quantified how mortality rates shifted across age brackets, sexes, and states.
Geographic differences across the United States were substantial in the model. In 2023, Washington, D.C., recorded the highest alcohol-attributable cancer mortality rates in the country, whereas Utah recorded the lowest rates.2 The authors noted that the findings carry acute relevance for states such as Florida, which maintains one of the largest proportions of older adults in the nation.2

What are the limits of the data?
The study relies on epidemiological attribution models rather than direct clinical tracking of individual patients. The estimates depend on population-level surveys of self-reported drinking habits, which frequently underestimate actual alcohol consumption. Furthermore, the mathematical models assume specific biological risk curves that may not capture complex interactions with diet, physical activity, or genetic predispositions across diverse communities.
The data cannot establish a definitive biological cutoff below which alcohol carries zero oncological risk. Elevated risk has been observed at intake levels between 5 and 15 grams of pure alcohol per day.1 Because the Centers for Disease Control and Prevention defines a standard drink in the United States as containing 14 grams of pure alcohol, consuming a single beverage daily can be enough to elevate risk.1 In 2019, the National Cancer Institute reported that alcohol accounted for about 5%, or nearly 100,000, of the 1.8 million cancer cases diagnosed in the nation, alongside about 4%, or roughly 25,000, of the approximately 600,000 cancer deaths that year.1
What steps could help reduce future risk?
Public health education regarding the oncological dangers of drinking remains far behind tobacco awareness. Early last year, the then surgeon general, Vivek Murthy, stated that alcohol use represents the third-leading preventable cause of cancer in the United States, trailing only tobacco use and obesity, and called for alcoholic beverages to carry warning labels about cancer hazards.1
Clinical leaders emphasize that alcohol intake represents an adjustable personal behavior. Dr. Chinmay Jani, corresponding author of the study and chief fellow in hematology and oncology at Sylvester, noted that the most critical takeaway is greater awareness that alcohol affects tissues beyond the liver.2 Because a completely safe threshold remains unproven, reducing alcohol intake to the lowest feasible level offers a direct way for individuals to lower their long-term cancer risk.2
What this rests on
18 sentences trace to 2 sources.
- 1 Alcohol-related cancer deaths in US have more than doubled over three decades See the source
- 2 Study: Alcohol-linked cancer’s toll extends far beyond the liver with deaths rising across age groups See the source